Serotonin 5-HT2C receptors regulate anxiety-like behavior

Genes, Brain and Behavior

Volumn 6, Issue 5, 2007, Pages 491-496

  Heisler, L K ^a   Zhou, L ^a   Bajwa, P ^b   Hsu, J ^b   Tecott, L H ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT2CR; Amygdala; Anxiety; BNST; CeA; Corticotropin releasing hormone; Knockout; Serotonin

Indexed keywords

AGOMELATINE; BENZODIAZEPINE; CORTICOTROPIN RELEASING FACTOR; GLEMANSERIN; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR;

AMYGDALOID NUCLEUS; ANALYTIC METHOD; ANXIETY DISORDER; ARTICLE; BEHAVIOR; CELL ACTIVATION; HUMAN; KNOCKOUT MOUSE; LOCOMOTION; NERVE CELL; NERVE CELL NETWORK; NONHUMAN; OPEN FIELD BEHAVIOR; PHENOTYPE; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

AMYGDALA; ANIMALS; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; EXPLORATORY BEHAVIOR; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONS; RECEPTOR, SEROTONIN, 5-HT2C;

MUS;

EID: 34347397785     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2007.00316.x     Document Type: Article

References (28)

1. Charney, D.S., Woods, S.W., Goodman, W.K. Heninger, G.R 1987) Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 92, 14 24.
2. Davis, M., Walker, D.L. Lee, Y 1997) Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos Trans R Soc Lond, B, Biol Sci 352, 1675 1687.
3. Gibson, E.L., Barnfield, A.M. Curzon, G 1994) Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects. Neuropharmacology 33, 457 465.
4. Griebel, G 1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65, 319 395.
5. Harada, K., Aota, M., Inoue, T., Matsuda, R., Mihara, T., Yamaji, T., Ishibashi, K., Matsuoka, N 2006) Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone. Eur J Pharmacol 553, 171 184.
6. Heisler, L.K., Chu, H.M., Brennan, T.J., Danao, J.A., Bajwa, P., Parsons, L.H. Tecott, L.H 1998) Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 95, 15049 15054.
7. Heisler, L.K., Cowley, M.A., Tecott, L.H., Fan, W., Low, M.J., Smart, J.L., Rubinstein, M., Tatro, J.B., Marcus, J.N., Holstege, H., Lee, C.E., Cone, R.D. Elmquist, J.K 2002) Activation of central melanocortin pathways by fenfluramine. Science 297, 609 611.
8. Kennett, G.A., Whitton, P., Shah, K. Curzon, G 1989) Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol 164, 445 454.
9. Kennett, G.A., Pittaway, K. Blackburn, T.P 1994) Evidence that 5-HT2C receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety. Psychopharmacology 114, 90 96.
10. Kennett, G.A., Wood, M.D., Bright, F., Trail, B., Riley, G., Holland, V., Avenell, K.Y., Stean, T., Upton, N., Bromidge, S., Forbes, I.T., Brown, A.M., Middlemiss, D.N. Blackburn, T.P 1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36, 609 620.
11. Kliethermes, C.L., Finn, D.A. Crabbe, J.C 2003) Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Psychopharmacology 169, 190 197.
12. Liu, H., Kishi, T., Roseberry, A.G., Cai, X., Lee, C.E., Montez, J.M., Friedman, J.M. Elmquist, J.K 2003) Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 23, 7143 7154.
13. Loo, H., Hale, A. D'haenen, H 2002) Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol 17, 239 247.
14. Lopez-Gimenez, J.F., Tecott, L.H., Palacios, J.M., Mengod, G. Vilaro, M.T 2002) Serotonin 5-HT(2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors. J Neurosci Res 67, 69 85.
15. Martin, J.R., Ballard, T.M. Higgins, G.A 2002) Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety. Pharmacol Biochem Behav 71, 615 625.
16. Millan, M.J., Brocco, M., Gobert, A., Dekeyne, A 2005) Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology 177, 448 458.
17. Molineaux, S.M., Jessell, T.M., Axel, R. Julius, D 1989) 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci U S A 86, 6793 6797.
18. Nic Dhonnchadha, B.A., Bourin, M. Hascoet, M 2003) Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Behav Brain Res 140, 203 214.
19. Simon, P., Dupuis, R. Costentin, J 1994) Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 61, 59 64.
20. Singewald, N., Salchner, P. Sharp, T 2003) Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53, 275 283.
21. Spina, M., Merlo-Pich, E., Chan, R.K., Basso, A.M., Rivier, J., Vale, W. Koob, G.F 1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273, 1561 1564.
22. Sramek, J.J., Robinson, R.E., Suri, A. Cutler, N.R 1995) Efficacy trial of the 5-HT2 antagonist MDL11,939 in patients with generalized anxiety disorder. J Clin Psychopharmacol 15, 20 22.
23. Stenzel-Poore, M.P., Heinrichs, S.C., Rivest, S., Koob, G.F. Vale, W.W 1994) Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 14, 2579 2584.
24. Swanson, L.W., Sawchenko, P.E., Rivier, J. Vale, W.W 1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36, 165 186.
25. Tecott, L.H., Sun, L.M., Akana, S.F., Strack, A.M., Lowenstein, D.H., Dallman, M.F. Julius, D 1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374, 542 546.
26. Toubas, P.L., Abla, K.A., Cao, W., Logan, L.G. Seale, T.W 1990) Latency to enter a mirrored chamber: a novel behavioral assay for anxiolytic agents. Pharmacol Biochem Behav 35, 121 126.
27. Treit, D. Fundytus, M 1988) Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 31, 959 962.
28. Weisstaub, N.V., Zhou, M., Lira, A., Lambe, E., Gonzalez-Maeso, J., Hornung, J.P., Sibille, E., Underwood, M., Itohara, S., Dauer, W.T., Ansorge, M.S., Morelli, E., Mann, J.J., Toth, M., Aghajanian, G., Sealfon, S.C., Hen, R. Gingrich, J.A 2006) Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313, 536 540.